Multiple hepatoprotectives (Heptral, Udliv, Hepamerz, Kabilyte) duplication, questionable clinical value
Unfortunately, many people have viewed overweight and obesity as a personal failing of not exercising or eating healthily enough
BI 456906: discovery and preclinical pharmacology of a novel GCGR/GLP-1R dual agonist with robust anti-obesity efficacy
Selectivity is the entire reason this compound exists, and it is worth being precise about what the word means here
They rely on consistent blood flow, stable glucose handling, healthy mitochondria, and intact myelin
If you have been prescribed or are considering a GLP-1 receptor agonist for diabetes or weight management, it is entirely appropriate to discuss thyroid cancer concerns with your doctor or specialist nurse